BackgroundCheck.run
Search For

Philip Livingston DeceasedHuntington Station, NY

Related to:
Mildred Livingston

Philip Livingston Phones & Addresses

Huntington Station, NY   

Bronx, NY   

Huntingtn Sta, NY   

Work

Company: MEMORIAL SLOAN KETTERING Address: 1275 York Ave Suite 113, New York, NY 10065 Phones: 888-6759875 (Phone) 212-7944352 (Fax)

Education

School / High School: Emory University 2029

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Allergy & Immunology, 1974
Get Report
Control this profile

Mentions for Philip Livingston

Career records & work history

Lawyers & Attorneys

Philip Livingston Photo 1

Philip Moore Livingston - Lawyer

Licenses:
Virginia - Authorized to practice law 2001
Philip Livingston Photo 2

Philip Livingston - Lawyer

Specialties:
Transactions, Leveraged Leases
ISLN:
1000083092
Admitted:
2001
Law School:
Georgetown University Law Center, JD - Juris Doctor

Medicine Doctors

Philip Livingston Photo 3

Dr. Philip O Livingston, New York NY - MD (Doctor of Medicine)

Specialties:
Rheumatology
Medical Oncology
Oncology
Address:
MEMORIAL SLOAN KETTERING
1275 York Ave Suite 113, New York, NY 10065
888-6759875 (Phone) 212-7944352 (Fax)
Certifications:
Allergy & Immunology, 1974
Internal Medicine, 1980
Medical Oncology, 1981
Rheumatology, 1974
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
MEMORIAL SLOAN KETTERING
1275 York Ave Suite 113, New York, NY 10065
Memorial Sloan - Kettering Cancer Center
1275 York Avenue, New York, NY 10065
Education:
Medical School
Emory University
Graduated: 2029
Medical School
Harvard Medical School
Graduated: 1969
Medical School
Cornell Med Ctr
Graduated: 1969
Medical School
Nyu Langone Medical Center
Graduated: 1969
Philip Livingston Photo 4

Philip Livingston, New York NY

Work:
Memorial Sloan-Kettering
1275 York Ave, New York, NY 10065
Philip Livingston Photo 5

Philip O Livingston, New York NY

Specialties:
Oncologist
Address:
1275 York Ave, New York, NY 10065
633 3Rd Ave, New York, NY 10017
156 E 79Th St, New York, NY 10075
Education:
Harvard Medical School - Doctor of Medicine
New York Presbyterian Hospital/Weill Cornell Medical Center - Residency - Family Medicine
New York Presbyterian Hospital/Weill Cornell Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Allergy and Immunology Certification in Allergy and Immunology
American Board of Internal Medicine Certification in Internal Medicine
American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
American Board of Internal Medicine Sub-certificate in Rheumatology (Internal Medicine)

Philip Livingston resumes & CV records

Resumes

Philip Livingston Photo 45

Philip Livingston

Philip Livingston Photo 46

Philip Livingston

Philip Livingston Photo 47

Philip Livingston

Publications & IP owners

Wikipedia

Philip Livingston Photo 49

Albany New York

…lbany's government and eventually expanded its power to control all of Albany County. Tories and prisoners of war were often jailed in the Stadt Huys alongside common criminals.[32] In 1776, Albany native Philip Livingston signed the Declaration of Independence at Independence Hall in Philad...

Us Patents

Synthesis Of Glycoconjugates Of The Globo-H Epitope And Uses Thereof

US Patent:
6544952, Apr 8, 2003
Filed:
Feb 2, 1998
Appl. No.:
09/017611
Inventors:
Samuel J. Danishefsky - Englewood NJ
Philip O. Livingston - New York NY
In Jong Kim - New York NY
Howard Scher - Tenafly NJ
Susan Slovin - New York NY
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
A01N11304
US Classification:
514 23, 514 42, 514 54, 514 62, 4241841, 4242771
Abstract:
The present invention provides a method of synthesizing a compound having the structure: as well as other related glycoconjugates useful as vaccines for inducing antibodies to epithelial cancer cells in an adjuvant therapy therefore, and in a method for preventing recurrence of epithelial cancer. The present invention also provides a vaccine comprising an amount of the compound described above effective to prevent the recurrence of cancer in a subject.

-O-Linked Glycoconjugates, Methods Of Preparation And Uses Thereof

US Patent:
6660714, Dec 9, 2003
Filed:
Mar 25, 1998
Appl. No.:
09/083776
Inventors:
Samuel J. Danishefsky - Englewood NJ
Dalibor Sames - New York NY
Samuel Hintermann - Basel, CH
Jacob B. Schwartz - Ann Arbor MI
Peter Glunz - Wilmington DE
Philip O. Livingston - New York NY
Scott Kuduk - Harleysville PA
Lawrence Williams - New York NY
Assignee:
Sloan Kettering Institute for Cancer Research - New York NY
International Classification:
A01N 3718
US Classification:
514 2, 514 8, 514 23, 514 25
Abstract:
The present invention provides novel -O-linked glycoconjugates such as -O-linked glycopeptides, as well convergent methods for synthesis thereof. The general preparative approach is exemplified by the synthesis of the mucin motif commonly found on epithelial tumor cell surfaces. The present invention further provides compositions and methods of treating cancer using the -O-linked glycoconjugates.

Ganglioslide-Klh Conjugate Vaccine Plus Qs-21

US Patent:
6916476, Jul 12, 2005
Filed:
Jun 7, 1995
Appl. No.:
08/481809
Inventors:
Philip Ordway Livingston - New York NY, US
Friedhelm Helling - New York NY, US
Assignee:
Sloan-Kettering Institute for Cancer Institute - New York NY
International Classification:
A61K039/385
A61K039/39
US Classification:
4241941, 4241931, 42419511, 4242821, 4242771, 4242781, 514 23, 514 25
Abstract:
This invention provides a vaccine for stimulating or enhancing in a subject to which the vaccine is administered, production of an antibody which recognizes a ganglioside, comprising an amount of ganglioside or oligosaccharide portion thereof conjugated to an immunogenic protein effective to stimulate or enhance antibody production in the subject, an effective amount of adjuvant and a pharmaceutically acceptable vehicle.

Ganglioside-Klh Conjugate Vaccines Plus Qs-21

US Patent:
6936253, Aug 30, 2005
Filed:
Jun 7, 1995
Appl. No.:
08/477097
Inventors:
Philip Ordway Livingston - New York NY, US
Friedhelm Helling - New York NY, US
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
A61K039/385
A61K039/39
US Classification:
4241941, 4241931, 42419511, 4242821, 4242771, 4242781, 514 23, 514 25
Abstract:
This invention provides a vaccine for stimulating or enhancing in a subject to which the vaccine is administered, production of an antibody which recognizes a ganglioside, comprising an amount of ganglioside or oligosaccharide portion thereof conjugated to an immunogenic protein effective to stimulate or enhance antibody production in the subject, an effective amount of adjuvant and a pharmaceutically acceptable vehicle.

Ganglioside-Klh Conjugate Vaccines Plus Qs-21

US Patent:
6967022, Nov 22, 2005
Filed:
Jun 7, 1995
Appl. No.:
08/475784
Inventors:
Philip Ordway Livingston - New York NY, US
Friedhelm Helling - New York NY, US
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
A61K039/385
A61K039/39
US Classification:
4241941, 4241931, 42419511, 4242821, 4242771, 4242781, 514 23, 514 25
Abstract:
This invention provides a vaccine for stimulating or enhancing in a subject to which the vaccine is administered, production of an antibody which recognizes a ganglioside, comprising an amount of ganglioside or oligosaccharide portion thereof conjugated to an immunogenic protein effective to stimulate or enhance antibody production in the subject, an effective amount of adjuvant and a pharmaceutically acceptable vehicle.

Ganglioside-Klh Conjugate Vaccine Plus Qs-21

US Patent:
7001601, Feb 21, 2006
Filed:
Jun 7, 1995
Appl. No.:
08/477147
Inventors:
Philip Ordway Livingston - New York NY, US
Friedhelm Helling - New York NY, US
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
A61K 39/385
A61K 39/39
US Classification:
4241941, 4241931, 42419511, 4242821, 4242771, 4242781, 4242801, 514 23, 514 25
Abstract:
This invention provides a vaccine for stimulating or enhancing in a subject to which the vaccine is administered, production of an antibody which recognizes a ganglioside, comprising an amount of ganglioside or oligosaccharide portion thereof conjugated to an immunogenic protein effective to stimulate or enhance antibody production in the subject, an effective amount of adjuvant and a pharmaceutically acceptable vehicle.

Ganglioside-Klh Conjugate Vaccines Plus Os-21

US Patent:
7014856, Mar 21, 2006
Filed:
Jan 21, 1994
Appl. No.:
08/196154
Inventors:
Philip Ordway Livingston - New York NY, US
Friedhelm Helling - New York NY, US
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
A61K 39/385
A61K 39/39
US Classification:
4241941, 4241931, 42419511, 4242821, 4242771, 4242781, 4242801, 514 23, 514 25
Abstract:
This invention provides a vaccine for stimulating or enhancing in a subject to which the vaccine is administered, production of an antibody which recognizes a ganglioside, comprising an amount of ganglioside or oligosaccharide portion thereof conjugated to an immunogenic protein effective to stimulate or enhance antibody production in the subject, an effective amount of adjuvant and a pharmaceutically acceptable vehicle.

Α-O-Linked Glycoconjugates, Methods Of Preparation And Uses Thereof

US Patent:
7160856, Jan 9, 2007
Filed:
Jul 25, 2002
Appl. No.:
10/205021
Inventors:
Samuel J. Danishefsky - Englewood NJ, US
Dalibor Sames - New York NY, US
Samuel Hintermann - Basel, CH
Xiao Tao Chen - Newark DE, US
Jacob B. Schwarz - Ann Arbor MI, US
Peter Glunz - Wilmington DE, US
Philip O. Livingston - New York NY, US
Scott Kuduk - Harleyville PA, US
Lawrence Williams - New York NY, US
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
A61K 38/14
A61K 39/385
C07K 9/00
US Classification:
514 8, 4241851, 4241941, 4242771, 530322
Abstract:
The present invention provides novel α-O-linked glycoconjugates such as α-O-linked glycopeptides, as well convergent methods for synthesis thereof. The general preparative approach is exemplified by the synthesis of the mucin motif commonly found on epithelial tumor cell surfaces. The present invention further provides compositions and methods of treating cancer using the α-O-linked glycoconjugates.

Isbn (Books And Publications)

Specific Immunotherapy Of Cancer With Vaccines

Author:
Philip Livingston
ISBN #:
0897668251

Possible Relatives

Cynthia L Livingston  David D Livingston  A A Livingston  Dawnell M Livingston  Dean W Livingston  Deanna L Livingston  Dale A Livingston  Philip E Johnson  Philip M Standifer  Philip E Johnston 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.